“The company’s Maharashtra site found in compliance to WHO good manufacturing practices (GMPs) for Pyrazinamide APIMF158 and Sulfadoxine APIMF234 active pharmaceutical ingredients (APIs),” Anuh Pharma said in a release.
Anuh Pharma on Thursday said that the World Health Organisation (WHO) has suspended its products – Pyrazinamide and Sulfadoxine – from prequalified list of active pharmaceutical ingredients (API).
Anuh Pharma LTD fails EDQM Inspection
Anuh Pharma has rallied 9% to Rs 339 on the BSE in early morning trade after the pharmaceutical company said that it has received World Health Organization (WHO) prequalification for the product Sulfadoxine.